AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 216 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $6,019,000 | -35.9% | 171,982 | -2.1% | 0.48% | -40.8% |
Q2 2020 | $9,392,000 | +65.8% | 175,612 | +10.0% | 0.81% | +60.9% |
Q1 2020 | $5,664,000 | -24.6% | 159,642 | +1.4% | 0.51% | 0.0% |
Q4 2019 | $7,515,000 | +99.2% | 157,375 | +35.2% | 0.51% | +72.1% |
Q3 2019 | $3,772,000 | -11.3% | 116,409 | +36.6% | 0.29% | -11.7% |
Q2 2019 | $4,251,000 | – | 85,229 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |